JP2022126804A5 - - Google Patents

Download PDF

Info

Publication number
JP2022126804A5
JP2022126804A5 JP2022101163A JP2022101163A JP2022126804A5 JP 2022126804 A5 JP2022126804 A5 JP 2022126804A5 JP 2022101163 A JP2022101163 A JP 2022101163A JP 2022101163 A JP2022101163 A JP 2022101163A JP 2022126804 A5 JP2022126804 A5 JP 2022126804A5
Authority
JP
Japan
Prior art keywords
disease
retinal
composition
seq
retinitis pigmentosa
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2022101163A
Other languages
English (en)
Japanese (ja)
Other versions
JP7427208B2 (ja
JP2022126804A (ja
Filing date
Publication date
Priority claimed from JP2020050903A external-priority patent/JP2020117513A/ja
Application filed filed Critical
Publication of JP2022126804A publication Critical patent/JP2022126804A/ja
Publication of JP2022126804A5 publication Critical patent/JP2022126804A5/ja
Priority to JP2024004787A priority Critical patent/JP2024026791A/ja
Application granted granted Critical
Publication of JP7427208B2 publication Critical patent/JP7427208B2/ja
Priority to JP2026007551A priority patent/JP2026063282A/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2022101163A 2016-09-02 2022-06-23 視覚機能再生剤又は視覚機能低下予防剤 Active JP7427208B2 (ja)

Priority Applications (2)

Application Number Priority Date Filing Date Title
JP2024004787A JP2024026791A (ja) 2016-09-02 2024-01-16 視覚機能再生剤又は視覚機能低下予防剤
JP2026007551A JP2026063282A (ja) 2016-09-02 2026-01-20 視覚機能再生剤又は視覚機能低下予防剤

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2016172149 2016-09-02
JP2016172149 2016-09-02
JP2020050903A JP2020117513A (ja) 2016-09-02 2020-03-23 視覚機能再生剤又は視覚機能低下予防剤

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
JP2020050903A Division JP2020117513A (ja) 2016-09-02 2020-03-23 視覚機能再生剤又は視覚機能低下予防剤

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2024004787A Division JP2024026791A (ja) 2016-09-02 2024-01-16 視覚機能再生剤又は視覚機能低下予防剤

Publications (3)

Publication Number Publication Date
JP2022126804A JP2022126804A (ja) 2022-08-30
JP2022126804A5 true JP2022126804A5 (https=) 2023-02-17
JP7427208B2 JP7427208B2 (ja) 2024-02-05

Family

ID=61301215

Family Applications (5)

Application Number Title Priority Date Filing Date
JP2018537436A Active JP6757024B2 (ja) 2016-09-02 2017-09-01 視覚機能再生剤又は視覚機能低下予防剤
JP2020050903A Withdrawn JP2020117513A (ja) 2016-09-02 2020-03-23 視覚機能再生剤又は視覚機能低下予防剤
JP2022101163A Active JP7427208B2 (ja) 2016-09-02 2022-06-23 視覚機能再生剤又は視覚機能低下予防剤
JP2024004787A Pending JP2024026791A (ja) 2016-09-02 2024-01-16 視覚機能再生剤又は視覚機能低下予防剤
JP2026007551A Pending JP2026063282A (ja) 2016-09-02 2026-01-20 視覚機能再生剤又は視覚機能低下予防剤

Family Applications Before (2)

Application Number Title Priority Date Filing Date
JP2018537436A Active JP6757024B2 (ja) 2016-09-02 2017-09-01 視覚機能再生剤又は視覚機能低下予防剤
JP2020050903A Withdrawn JP2020117513A (ja) 2016-09-02 2020-03-23 視覚機能再生剤又は視覚機能低下予防剤

Family Applications After (2)

Application Number Title Priority Date Filing Date
JP2024004787A Pending JP2024026791A (ja) 2016-09-02 2024-01-16 視覚機能再生剤又は視覚機能低下予防剤
JP2026007551A Pending JP2026063282A (ja) 2016-09-02 2026-01-20 視覚機能再生剤又は視覚機能低下予防剤

Country Status (6)

Country Link
US (2) US11932679B2 (https=)
EP (2) EP4653537A3 (https=)
JP (5) JP6757024B2 (https=)
CN (5) CN109890404A (https=)
ES (1) ES3059584T3 (https=)
WO (1) WO2018043707A1 (https=)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP4653537A3 (en) 2016-09-02 2026-01-07 Keio University Rhodopsin gene therapy for regenerating visual function or for preventing deterioration in visual function
WO2020148913A1 (ja) * 2019-01-18 2020-07-23 俊英 栗原 網膜疾患の予防および進行抑制、視覚認知行動機能の改善、および視覚機能強化
US11771741B2 (en) 2019-09-13 2023-10-03 Restore Vision Inc. Nucleic acid construct that encodes chimeric rhodopsin
WO2021049634A1 (ja) * 2019-09-13 2021-03-18 株式会社レストアビジョン キメラロドプシンをコードする核酸コンストラクト
CN114729009A (zh) 2019-10-31 2022-07-08 伯尔尼大学 用于眼部基因递送的aav载体变体
CA3195696A1 (en) * 2020-09-17 2022-03-24 Restore Vision Inc. Composition for treating or preventing diseases, disorders, or conditions associated with endoplasmic reticulum stress or all-trans-retinal, protecting retinal thickness, or suppressing reduction in retinal thickness or progress of reduction in retinal thickness
CN118717946A (zh) * 2023-03-29 2024-10-01 郑州大学第一附属医院 一种嵌合蛋白在治疗视神经变性疾病中的应用
CN118791624B (zh) * 2023-04-11 2026-04-03 苏州星明优健生物技术有限公司 用于治疗视网膜神经退行性疾病的新型gpcr嵌合视蛋白

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3521382B2 (ja) 1997-02-27 2004-04-19 日本たばこ産業株式会社 細胞間接着及びシグナル伝達を媒介する細胞表面分子
CN101484005A (zh) 2006-05-04 2009-07-15 韦恩州立大学 通过向体内递送视紫红质核酸恢复视觉响应
KR101197129B1 (ko) 2009-09-14 2012-11-07 서강대학교산학협력단 글레오박터 로돕신 및 atp 합성효소가 방향성을 갖도록 장착된 atp 합성용 조성물
EP2547762B1 (en) 2010-03-17 2018-04-25 The Board of Trustees of the Leland Stanford Junior University Light-sensitive ion-passing molecules
KR101061482B1 (ko) 2010-04-20 2011-09-02 서강대학교산학협력단 카로테노이드가 재구성된 글레오박터 로돕신
WO2012061679A2 (en) 2010-11-05 2012-05-10 The Board Of Trustees Of The Leland Stanford Junior University Light-activated chimeric opsins and methods of using the same
EP2968476B1 (en) 2013-03-14 2021-05-05 Wayne State University A plasmin for use in enhancing delivery of therapeutic compounds to the eyes or for improving vision
EP4678754A3 (en) * 2014-03-11 2026-04-08 Wayne State University A modified mglur6 promoter and methods of use
EP4653537A3 (en) 2016-09-02 2026-01-07 Keio University Rhodopsin gene therapy for regenerating visual function or for preventing deterioration in visual function
WO2020148913A1 (ja) 2019-01-18 2020-07-23 俊英 栗原 網膜疾患の予防および進行抑制、視覚認知行動機能の改善、および視覚機能強化
US11771741B2 (en) 2019-09-13 2023-10-03 Restore Vision Inc. Nucleic acid construct that encodes chimeric rhodopsin
WO2021049634A1 (ja) 2019-09-13 2021-03-18 株式会社レストアビジョン キメラロドプシンをコードする核酸コンストラクト

Similar Documents

Publication Publication Date Title
JP2022126804A5 (https=)
JP2021534798A5 (https=)
JP2021503914A5 (https=)
Wiener et al. The sequences of the reovirus serotype 1, 2, and 3 L1 genome segments and analysis of the mode of divergence of the reovirus serotypes
PH12020550706A1 (en) Adeno-associated virus variant capsids and use for inhibiting angiogenesis
JP2008529536A5 (https=)
JP2019089787A5 (https=)
WO2019060454A3 (en) Adeno-associated virus variant capsids and methods of use thereof
JP2022506111A5 (https=)
JP2015501156A5 (https=)
JP2022535745A5 (https=)
WO2017197355A3 (en) Adeno-associated virus variant capsids and methods of use thereof
JP2017506521A5 (https=)
JP2018523668A5 (https=)
CN103396494B (zh) 一种凝血因子ix的单克隆抗体
JP2023504773A5 (https=)
JP2023522154A5 (https=)
JP2003503355A5 (https=)
JPWO2019156137A5 (https=)
JP2022505585A5 (https=)
JP2021525531A5 (https=)
JP2025513072A5 (https=)
JP2022536945A5 (https=)
JP2024503091A5 (https=)
FI3561056T3 (fi) Peptidi silmänpohjan ikärappeuman hoitamiseksi